1. Home
  2. companies
  3. Japan

Japan

Here’s What Cosentyx’s Approval In Japan Means For Novartis
Here’s What Cosentyx’s Approval In Japan Means For Novartis
Bidness Etc.
Cosentyx
Japan
drug approvals
Novartis
psoriatic arthritis
Glaxo to Take 25% Stake in Aspen Pharmacare Japanese Unit
Glaxo to Take 25% Stake in Aspen Pharmacare Japanese Unit
Bloomberg
GSK
Aspen
Japan
M&A
Japanese Research Scandal Involving Novartis Blood Pressure Drug Widens
Japanese Research Scandal Involving Novartis Blood Pressure Drug Widens
Forbes
Novartis
Japan
Diovan
Sanofi appoints Japan exec to lead U.S. pharma ops
Sanofi appoints Japan exec to lead U.S. pharma ops
Fierce Biotech
Sanofi
Japan
Japan’s Eisai Steps Up Push in Cancer Drugs
Japan’s Eisai Steps Up Push in Cancer Drugs
WSJ Online
Japan
Eisai
thyroid cancer
Lenvatinib
Novartis apologizes for not disclosing side-effects of leukemia drugs sooner
Novartis apologizes for not disclosing side-effects of leukemia drugs sooner
Reuters
Novartis
side effects
Japan
leukemia
Bristol-Myers hepatitis C drug gets approval in Japan
Bristol-Myers hepatitis C drug gets approval in Japan
Yahoo/Reuters
Bristol-Myers Squibb
Japan
hepatitis C
Novartis Japan unit faces another criminal charge in data-manipulation scandal
Novartis Japan unit faces another criminal charge in data-manipulation scandal
Fierce Pharma
Novartis
data manipulation
fraud
Japan
Gilead Seeks Japanese Approval for Sovaldi
Gilead Seeks Japanese Approval for Sovaldi
Yahoo/Zacks.com
Japan
hepatitis C
Sovaldi
Gilead Sciences
Novartis Japan’s Office Raided by Prosecutors, Adding to Probes
Novartis Japan’s Office Raided by Prosecutors, Adding to Probes
Bloomberg
Novartis
Japan
Diovan
How Many? Novartis Says 10,000 Side Effect Cases Were Never Filed
How Many? Novartis Says 10,000 Side Effect Cases Were Never Filed
WSJ Online
side effects
adverse events
Novartis
Japan
Trials Are Expected In Japan And China, But Arena's Belviq International Sales Will Have To Wait
Trials Are Expected In Japan And China, But Arena's Belviq International Sales Will Have To Wait
Seeking Alpha
Japan
China
Arena Pharmaceuticals
Belviq
obesity
Eisai
Merck Sells Eye Products to Santen
Merck Sells Eye Products to Santen
Bloomberg
Merck
eye health
Santen
Japan
Japanese officials: Novartis failed to report side effects of leukemia drug
Japanese officials: Novartis failed to report side effects of leukemia drug
Fierce Pharma
Tasigna
Novartis
Japan
Novartis replaces senior management at Japanese unit amid leukaemia drug study probe
Novartis replaces senior management at Japanese unit amid leukaemia drug study probe
First Word Pharma
Novartis
Japan
Novartis Japan staffers shredded and deleted to cover trial misconduct, panel finds
Novartis Japan staffers shredded and deleted to cover trial misconduct, panel finds
Fierce Pharma
Novartis
Japan
clinical trial data
Gilead says Japanese hepatitis C trial meets goal
Gilead says Japanese hepatitis C trial meets goal
Yahoo/Reuters
Gilead Sciences
Japan
hepatitis C
sofosbuvir
AstraZeneca takes control of its destiny in Japan with buyout; drugmaker snatches up Sumitomo and gets Forxiga approval there
AstraZeneca takes control of its destiny in Japan with buyout; drugmaker snatches up Sumitomo and gets Forxiga approval there
Fierce Pharma
M&A
Japan
Forixga
Dainippon Sumitomo
AstraZeneca
Tokyo hospital exec says Novartis employees deeply involved in leukemia-drug trial
Tokyo hospital exec says Novartis employees deeply involved in leukemia-drug trial
Fierce Pharma
Novartis
Japan
Tasigna
Sun Pharma says seeks to enter Japan generics market
Sun Pharma says seeks to enter Japan generics market
Yahoo/Reuters
India
Japan
Sun Pharma
generics

Click here to subscribe to daily news headlines in your email inbox